Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Drug standard and legislation
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Drug standard and legislation
S.959—Pharmaceutical Compounding Quality, Security and Accountability Act, was introduced into the U.S Senate May 15, 2013 by Thomas Harkin, Democratic senator of Iowa, along with the support of five cosponsors. The bill, if it’d passed would have amended the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the regulation of compounded drugs. It would have allowed the Federal Government to oversee drug compounders’ operations to ensure drug quality and safety. Most recently, the bill was referred to the Senate Health, Education, Labor, and Pensions Committee but never made it to the floor for a vote. Supporters of S.959 were both Republicans and Democrats. This bill was a bipartisan effort. There was opposition to this bill from the International Academy of Compounding Pharmacists, who argued that the bill would not serve as a safeguard for Americans and cause unnecessary regulation. I support the passing of this bill. Regulation of compounded drugs is in the best interest to the public’s health and welfare. This would’ve stopped contaminated drugs from entering the market as well as lessening the amount of counterfeit drugs on the market.
The Federal Food, Drug and Cosmetic Act (FFDCA) was in the process of being amended with S.959. This bill would have amended FFDCA to include the regulation of drug compounding manufacturers’ operations to ensure drug quality and safety. S.959’s creation came about after an outbreak of fungal meningitis in September 2012 caused by a contaminated shipment of steroids, distributed by a drug compounding manufacturer named New England Compounding Center (NECC) which caused serious illnesses and death (Szabo, 2013), the Center for Disease Control (CDC) reported “as of Oct. 1, there were 750 ...
... middle of paper ...
...DC: CRS.
Editoral Board (2012). Bringing compounding pharmacies under federal regulation. The Washington Post.
IACP. (2013, July 30). IACP Message Points: Why the Current Draft of S. 959 is Still Unworkable. Retrieved from IACP : http://iacprx.org/displaycommon.cfm?an=1&subarticlenbr=670
James A. Morone, Rogan Kersh. (2013). Interest groups: them or us?, By The People (pp. 408-409). New York: Oxford University Press.
Martin, T. W. (2013, September 9 ). Dangers from compounding pharmacies persist. The wall street journal.
Morris, M. (2013, September 26). Bill would regulate large-scale compounding pharmacies. The Kansas Star.
The partnership for public service (2013, October 14). Rapid CDC response to meningitis outbreak from tainted steroid saved lives. The Washington Post
Szabo, L. (2013, August 11). FDA: New voluntary recall from compounding pharmacy. USA Today.
Dr. John Abramson’s book Overdosed America debunks the myths about the excellence of American medicine. Abramson backs up this claim by closely examining research about medicine, closely examining the unpublished details submitted by drug manufacturers to the FDA, and discovering that the unpublished data does not coincide with the claims made about the safety and effectiveness of commonly used medicines. Abramsons purpose is to point out the flaws of the pharmaceutical industry in order to warn the readers about the credibility of the drugs they are buying. Given the critical yet technical language of the book, Abramson is writing to an audience that may include academic physicians as well as those who want to learn about the corruption of the pharmaceutical industry.
and yet simple of the act, which severely impacts pharmacy and is forbidden by the PDMA, is the act of knowingly trading, purchasing, or knowingly selling a prescription drug sample. This offense is punishable for a fine of up to two hundred and fifty- thousand dollars, and up to ten years of imprisonment. Many pharmacists do not realize is that there is a fee of up to one hundred and twenty five thousand dollars for the individuals who provide information leading to the conviction of a violator of the PDMA. Another important portion of this vast law is that it prohibits pharmacists to resale of any prescription drug that was previously purchased by hospitals or any other health care facility. The provision was intended to eliminate a major source of drugs in the diversion market such as; drugs that were originally purchased by hospitals or health care facilities at substantially discounted prices, as allowed by the Nonprofit Institutions Act of 1938, and then resold to the retail class of trade. Congress believed that the resale of such drugs created an unfair for of competition. Re...
According to the 2002 Harris poll, seven out of ten adults in the United States take vitamins, minerals, herbs, or other supplements (Schardt 2). Due to media advertising, dietary supplements are becoming more popular. Companies compete to have the best supplements. It is said that forty percent of American adults take vitamin supplements and over the counter products, which total in several billion dollars (Farley 2). Although many of the supplements claim to be healthy and help lose weight, the dangers are endless. Dietary supplements can be illegally spiked and are not safe. Therefore, putting regulations on dietary supplements and their safety hazards is necessary.
In August of 2001 Robert Ray Courtney was arrested in Kansas City, Missouri and charged with diluting drugs used to treat cancer patients. Courtney’s actions not only violated criminal and civil laws but they shattered the ethical code and the oath he took as a licensed pharmacist. His actions left many people wondering why anyone would commit such a horrible act, let alone a trusted pharmacist who was providing medication to patients whose very lives depended on him doing his job.
Government factors into the equation of the argument. Critics of the drug industry say that there is not enough regulation, while supporters of the pharmaceutical companies argue that there is too much regulation and that that is one...
South University Online. (2013). POL2076: American Government: Week 4: People and Politics—Interest Groups. Retrieved from http://myeclassonline.com
Michael Asanasious#2769752 Professor Sharifan GOVT 2306 April 15, 2017 Interest Groups, Lobbyists, and Lawmakers The Iron Triangle Have you wondered why interest groups have become so powerful?
... middle of paper ... ... Six years later, in 2001, the majority of their income came from services to pharmaceutical companies (Martinez). This shows a definitive shift in the conduct of PBM’s.
Essentially, interest groups use many different tactics to accomplish their central goals but this paper will detail 2 of them. The first being lobbying, which is the act of persuading businesses as well as government leaders to help a specific organization by changing laws or creating events in favor of that group. Interest groups use this technique by hiring someone to represent them and advocate their cause to on the behalf of the entire group. These hired representatives usually have more than enough experience within the political field and are able to persuade connections within the government for help with their concerns. This method gets a lot of criticism because although lobbyist offer their input to government officials on pending laws, they only look at what is favorable for their cause. When trying to make a difference you have to not only reflect on your argument but on the side affects of that argument as
Over the last decade, Southwest border violence has elevated into a national security concern. Much of the violence appears to stem from the competing growth and distribution networks that many powerful Mexican drug cartels exercise today. The unfortunate byproduct of this criminality reaches many citizens of the Mexican border communities in the form of indiscriminate street gang shootings, stabbings, and hangings which equated to approximately 6,500 deaths in 2009 alone (AllGov, 2012). That same danger which now extends across the border regions of New Mexico, Arizona, Texas, and California has the potential for alarming escalation. Yet, despite the violence, evermore-brazen behavior continues to grow, as does America’s appetite for drugs. Even though drug-related violence mandates that law enforcement agencies focus on supply reduction, the Office of National Drug Control Policy should shift its present policy formulation efforts to only drug demand reduction because treatment and prevention efforts are inadequate and strategy has evolved little over the last three decades.
The drug control policy of the United States has always been a subject of debate. From Prohibition in the early 1930’s to the current debate over the legalization of marijuana, drugs have always been near the top of the government’s agenda. Drug use affects every part of our society. It strains our economy, our healthcare, our criminal justice systems, and it endangers the futures of young people. In order to support a public health approach to drug control, the Obama administration has committed over $10 billion to drug education programs and support for expanding access to drug treatment for addicts (Office). The United States should commit more government resources to protect against illegal use of drugs by youths and provide help for recovering addicts.
The National Drug Control Strategy was issued two years ago to reduce drug use among teenagers and adults. The success of the President’s drug policy can be measured by its results. The student drug testing approach has reduced drug use and discouraged first time users significantly. Communities have been more actively involved in anti-drug programs for youth and adults. The increase in budget for law enforcement will enhance their effectiveness in detaining drug lords and cartels.
The war on drugs and the violence that comes with it has always brought around a hot debate about drug legalization. The amount of violence that is associated with drugs is a result from harsher drug laws and prohibition.
Compounding is a fundamental aspect of pharmacy practice. Understanding appropriate procedures for processing, packaging, storing, and labeling is essential for dispensing a quality product. Additionally, it is important to be aware of oversight/regulation of pharmacy compounding so that procedures are carried out in a manner that ensures the safety of both the patient and practitioner.
U.S. Food and Drug Administration. "Dietary Supplement Health and Education Act of 1994". December 1, 1995.